Publication | Open Access
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
17
Citations
33
References
2021
Year
Our results suggest that TMEFF2 DNA methylation might be associated with glioma tumour progression and could serve as a valuable prognostic marker for adult diffuse gliomas.
| Year | Citations | |
|---|---|---|
Page 1
Page 1